Funder: Gilead Sciences
Due Dates: Not specified (invitational/rolling basis; check program page)
Funding Amounts: Multi-million dollar initiative; individual award sizes not specified; five-year program (2019–2024).
Summary: Funds programs combating hepatitis C linked to the opioid crisis via screening, harm reduction, and healthcare infrastructure in Indiana, Kentucky, North Carolina, Tennessee, and West Virginia.
Key Information: Focused on community partnerships in five Appalachian states; priority for harm reduction, screening, and healthcare access.